品牌 |
貨號(hào) |
產(chǎn)品名稱 |
規(guī)格 |
貨期 |
單價(jià) |
操作 |
LC Laboratories | T-5335 | Tubastatin A, Hydrochloride Salt[1310693-92-5] | 100 mg | | ¥0 | 詳情 |
LC Laboratories | T-5335 | Tubastatin A, Hydrochloride Salt[1310693-92-5] | 50 mg | | ¥0 | 詳情 |
LC Laboratories | T-5335 | Tubastatin A, Hydrochloride Salt[1310693-92-5] | 25 mg | | ¥0 | 詳情 |
LC Laboratories | T-5335 | Tubastatin A, Hydrochloride Salt[1310693-92-5] | 10 mg | | ¥0 | 詳情 |
LC Laboratories | T-5335 | Tubastatin A, Hydrochloride Salt[1310693-92-5] | 5 mg | | ¥0 | 詳情 |
LC Laboratories | T-1399 | Tofacitinib, Citrate Salt[540737-29-9] | 5 g | | ¥0 | 詳情 |
LC Laboratories | T-1399 | Tofacitinib, Citrate Salt[540737-29-9] | 2 g | | ¥0 | 詳情 |
LC Laboratories | T-1399 | Tofacitinib, Citrate Salt[540737-29-9] | 1 g | | ¥0 | 詳情 |
LC Laboratories | T-1399 | Tofacitinib, Citrate Salt[540737-29-9] | 500 mg | | ¥0 | 詳情 |
LC Laboratories | T-1399 | Tofacitinib, Citrate Salt[540737-29-9] | 200 mg | | ¥0 | 詳情 |
LC Laboratories | T-1399 | Tofacitinib, Citrate Salt[540737-29-9] | 100 mg | | ¥0 | 詳情 |
LC Laboratories | T-1399 | Tofacitinib, Citrate Salt[540737-29-9] | 50 mg | | ¥0 | 詳情 |
LC Laboratories | T-1399 | Tofacitinib, Citrate Salt[540737-29-9] | 25 mg | | ¥0 | 詳情 |
LC Laboratories | T-1377 | Tofacitinib, Free Base[477600-75-2] | 2 g | | ¥0 | 詳情 |
LC Laboratories | T-1377 | Tofacitinib, Free Base[477600-75-2] | 1 g | | ¥0 | 詳情 |
LC Laboratories | T-1377 | Tofacitinib, Free Base[477600-75-2] | 500 mg | | ¥0 | 詳情 |
LC Laboratories | T-1377 | Tofacitinib, Free Base[477600-75-2] | 200 mg | | ¥0 | 詳情 |
LC Laboratories | T-1377 | Tofacitinib, Free Base[477600-75-2] | 100 mg | | ¥0 | 詳情 |
LC Laboratories | T-1377 | Tofacitinib, Free Base[477600-75-2] | 50 mg | | ¥0 | 詳情 |
LC Laboratories | T-1377 | Tofacitinib, Free Base[477600-75-2] | 25 mg | | ¥0 | 詳情 |